Identification |
Name: | Methanone,[4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl](tetrahydro-2-furanyl)- |
Synonyms: | Piperazine,1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]-(9CI);1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(tetrahydro-2-furoyl)piperazine;1-(4-Amino-6,7-dimethoxyquinazolin-2-yl)-4-[(2,3,4,5-tetrahydrofuran-2-yl)carbonyl]piperazine;Terazosin;Fosfomic;Vasomet;Terazosina;Terazosine;Flumarc;Blavin; |
CAS: | 63590-64-7 |
Molecular Formula: | C19H25N5O4 |
Molecular Weight: | 459.9244 |
InChI: | InChI=1S/C19H25N5O4.ClH.2H2O/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14;;;/h10-11,14H,3-9H2,1-2H3,(H2,20,21,22);1H;2*1H2 |
Molecular Structure: |
|
Properties |
Density: | 1.332 g/cm3 |
Stability: | Stable at normal temperatures and pressures. |
Water Solubility: | H2O: 25 mg/mL in water |
Solubility: | H2O: 25 mg/mL in water |
Appearance: | powder |
Storage Temperature: | Keep tightly closed. Store in a cool dry place. |
Color: | white to off-white |
Usage: | An a-1-adrenergicblocker related to prazosin |
Safety Data |
Hazard Symbols |
Xn: Harmful
|
|
|